Taylor ChartieFounder

United States - Austin, Texas Metropolitan Area

Taylor Chartier is a former data scientist and engineer from the pharmaceutical industry. She has supported FDA Biologics License Applications by advancing Quality by Design initiatives in Process Development, Manufacturing Sciences and Technology, and Commercial Manufacturing operations. She has also applied machine learning and artificial intelligence for multivariate modeling to optimize pharmaceutical production and perform root cause analysis, most recently at Bayer Pharmaceuticals. Her education consists of a 5-year accelerated bachelors and masters program in chemical engineering at the University of Rochester, NY, and she was most recently pursuing a PhD in applied AI with wearables research for Parkinson’s patients at the University of Luxembourg.

During her time supporting various technical initiatives in pharma, she became very familiar with the challenges the sector faces to maintain product quality. It was in this capacity that she recognized the significant potential for AI in process development and commercial drug manufacturing. So Chartier started the AI software company, Modicus Prime, to provide pharma with the right AI computational techniques and apply them in a vigorous way to help safely and more efficiently produce drugs for patients. Modicus Prime’s computer vision software automates biologics image analysis and is designed to solve for the cost, legal, and waste liabilities from product quality failures across R&D and manufacturing. Modicus Prime is venture-backed and has strategic partnerships with organizations including Takeda Pharmaceuticals, Oak Ridge National Laboratory (DOE), eLabNext (Eppendorf), Dotmatics, PlugandPlay Health, and Techstars. Modicus Prime is also a resident of Johnson&Johnson JLABS at the Texas Medical Center. The company’s proprietary GxP-compliant software, mpVision, enables scientists to independently train their own AI to achieve real-time classification of any imaging data – from biologic morphology analysis to commercial contamination detection – for comprehensive quality control across R&D and manufacturing. mpVision has been globally tested by scientists at a Top 10 Pharma, and its features are mapped to the unmet needs of the pharmaceutical industry, including real-time product quality assurance, full agency compliance, faster go-to-market, and reduced operating costs.